NO179748C - Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-(1H-indol-3-yl)-maleinimidderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-(1H-indol-3-yl)-maleinimidderivater

Info

Publication number
NO179748C
NO179748C NO901989A NO901989A NO179748C NO 179748 C NO179748 C NO 179748C NO 901989 A NO901989 A NO 901989A NO 901989 A NO901989 A NO 901989A NO 179748 C NO179748 C NO 179748C
Authority
NO
Norway
Prior art keywords
indol
preparation
therapeutically active
analogous process
active bis
Prior art date
Application number
NO901989A
Other languages
English (en)
Norwegian (no)
Other versions
NO179748B (no
NO901989L (no
NO901989D0 (no
Inventor
Hubert Barth
Johannes Hartenstein
Claus Rudolph
Christoph Schachtele
Hans-Jurgen Betche
Hartmut Osswald
Reinhard Reck
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3914764A external-priority patent/DE3914764A1/de
Priority claimed from DE19893942991 external-priority patent/DE3942991A1/de
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of NO901989D0 publication Critical patent/NO901989D0/no
Publication of NO901989L publication Critical patent/NO901989L/no
Publication of NO179748B publication Critical patent/NO179748B/no
Publication of NO179748C publication Critical patent/NO179748C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Image Processing (AREA)
  • Aerodynamic Tests, Hydrodynamic Tests, Wind Tunnels, And Water Tanks (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO901989A 1989-05-05 1990-05-04 Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-(1H-indol-3-yl)-maleinimidderivater NO179748C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3914764A DE3914764A1 (de) 1989-05-05 1989-05-05 Maleinimid-derivate und deren verwendung als arzneimittel
DE19893942991 DE3942991A1 (de) 1989-12-27 1989-12-27 Maleinimid-derivate und deren verwendung als arzneimittel

Publications (4)

Publication Number Publication Date
NO901989D0 NO901989D0 (no) 1990-05-04
NO901989L NO901989L (no) 1990-11-06
NO179748B NO179748B (no) 1996-09-02
NO179748C true NO179748C (no) 1996-12-11

Family

ID=25880591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901989A NO179748C (no) 1989-05-05 1990-05-04 Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-(1H-indol-3-yl)-maleinimidderivater

Country Status (16)

Country Link
EP (1) EP0397060B1 (fr)
JP (1) JP2983248B2 (fr)
KR (1) KR900018080A (fr)
AT (1) ATE209202T1 (fr)
AU (1) AU634541B2 (fr)
CA (1) CA2015996C (fr)
DE (1) DE59010927D1 (fr)
DK (1) DK0397060T3 (fr)
ES (1) ES2169719T3 (fr)
FI (1) FI902251A7 (fr)
HU (1) HU207727B (fr)
IL (1) IL94274A0 (fr)
NO (1) NO179748C (fr)
NZ (1) NZ233560A (fr)
PT (1) PT93947B (fr)
YU (1) YU87990A (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
DE4005970A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
CA2046801C (fr) * 1990-08-07 2002-02-26 Peter D. Davis Pyrroles substitues
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides
AU3761393A (en) * 1992-03-20 1993-10-21 Wellcome Foundation Limited, The Indole derivatives with antiviral activity
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
US5405864A (en) * 1993-10-15 1995-04-11 Syntex (U.S.A.) Inc. Chemotherapeutic maleimides
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
PT657458E (pt) * 1993-12-07 2002-02-28 Lilly Co Eli Inibidores de proteina cinase c
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
EP0657411B1 (fr) * 1993-12-07 1999-06-09 Eli Lilly And Company Synthese de Bisindolylmaleimides
CA2179650C (fr) 1993-12-23 2007-10-30 William Francis Heath, Jr. Bis-indolemaleimides et utilisation connexe comme inhibiteurs de la proteine kinase c
DE69532198T2 (de) * 1994-05-09 2004-08-26 Banyu Pharmaceutical Co., Ltd. Antitumor-indolopyrolocarbazolderivat
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5559228A (en) * 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides
PL184728B1 (pl) * 1995-11-20 2002-12-31 Lilly Co Eli Nowe pochodne bisindolilomaleimidu z mostkiem N,N'i środek farmaceutyczny
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91698A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
SE9603283D0 (sv) * 1996-09-10 1996-09-10 Astra Ab New compounds
CA2268399C (fr) * 1996-10-31 2008-08-19 Harbor Branch Oceanographic Institution, Inc. Composes et compositions inflammatoires antineurogenes et methodes d'utilisation
AU2548699A (en) * 1998-02-23 1999-09-06 Rei Asakai Cell death inhibitors
ATE277010T1 (de) * 1998-07-08 2004-10-15 Harbor Branch Oceanographic Bis-indolederivate und ihre verwendung als entzündungshemmende mittel
EP1152002A4 (fr) 1999-02-09 2002-04-17 Sagami Chem Res Derives de pyrrole et inhibiteurs de la mort cellulaire
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US7129250B2 (en) 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (fr) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Composes neuroprotecteurs
DE10109280A1 (de) * 2001-02-26 2002-09-05 Peter Mayser Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
DE60213842T2 (de) 2001-10-30 2007-09-06 Novartis Ag Staurosporin-derivate als hemmer der flt3-rezeptor-tyrosinkinase-wirkung
CA2393720C (fr) 2002-07-12 2010-09-14 Eli Lilly And Company Monochlorhydrate de 3-(1-methyl-1h-indol-3-yl)-4-[[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole-2,5-dione cristallin
CA2522712A1 (fr) * 2003-04-18 2004-10-28 Kyowa Hakko Kogyo Co., Ltd. Medicament pour la regeneration des nerfs
KR100941205B1 (ko) 2005-02-09 2010-02-10 아르퀼 인코포레이티드 말레이미드 유도체, 약제학적 조성물 및 암을 치료하는방법
EP2170870B1 (fr) 2007-06-22 2014-03-05 ArQule, Inc. Dérivés de pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine et thiosuccinimide, compositions et procédés pour le traitement d'un cancer
KR20100024494A (ko) 2007-06-22 2010-03-05 아르퀼 인코포레이티드 퀴나졸리논 화합물 및 이의 사용 방법
CA2912546A1 (fr) 2007-06-22 2008-12-31 Arqule, Inc. Compositions et procedes de traitement du cancer
US8193235B2 (en) * 2009-06-12 2012-06-05 University Of Kansas Compositions and methods for establishing and maintaining stem cells in an undifferentiated state
EP3741375A1 (fr) 2014-07-17 2020-11-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédés de traitement de maladies associées aux jonctions neuromusculaires
WO2016207366A1 (fr) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et compositions pharmaceutiques de traitement d'infections virales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders

Also Published As

Publication number Publication date
NO179748B (no) 1996-09-02
IL94274A0 (en) 1991-03-10
AU5466690A (en) 1990-11-08
FI902251A0 (fi) 1990-05-04
AU634541B2 (en) 1993-02-25
NO901989L (no) 1990-11-06
EP0397060A3 (fr) 1992-01-02
HU207727B (en) 1993-05-28
ES2169719T3 (es) 2002-07-16
KR900018080A (ko) 1990-12-20
EP0397060B1 (fr) 2001-11-21
NZ233560A (en) 1992-01-29
HUT53902A (en) 1990-12-28
CA2015996A1 (fr) 1990-11-05
DE59010927D1 (de) 2002-01-03
FI902251A7 (fi) 1990-11-06
JP2983248B2 (ja) 1999-11-29
PT93947B (pt) 1996-11-29
HU902681D0 (en) 1990-09-28
YU87990A (sh) 1992-07-20
ATE209202T1 (de) 2001-12-15
JPH02306974A (ja) 1990-12-20
CA2015996C (fr) 2001-08-28
NO901989D0 (no) 1990-05-04
PT93947A (pt) 1991-01-08
EP0397060A2 (fr) 1990-11-14
DK0397060T3 (da) 2002-05-21

Similar Documents

Publication Publication Date Title
NO179748C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-(1H-indol-3-yl)-maleinimidderivater
NO944564D0 (no) Indolcarbazol-imider og deres anvendelse
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
NO177785C (no) Analogifremgangsmåter for fremstilling av terapeutisk aktive alkoksy-4(1H)-pyridonderivater
NO174772C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive piperazinylderivater
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
EP0434057A3 (en) Indolocarbazole derivatives, processes for their preparation and their use
NO169492C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2',3'-dideoksy-2'-fluornukleosider
FI884553A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi
NO179249C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4,6- disubstituerte 2,3-dikarboksylsyreindolderivater
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
DK0632028T3 (da) Optisk aktivt 2-nitroimidazolderivat, fremgangsmåde til fremstilling af samme og mellemprodukt til fremstilling af samme
FI922267L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3-isoksatsolyyli-4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
HU896587D0 (en) 2-amino-carbonic acid derivatives, and medical preparations containing them as active agents, and process for the production of the active agents and the preparation
NO902749L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme bis-(benzylpyrrolidin)-derivater.